InMode (INMD) Interest & Investment Income (2018 - 2026)
InMode (INMD) posted quarterly Interest & Investment Income of $4.3 million for Q1 2026, down 37.37% year-on-year from $6.9 million in Q1 2025, and down 18.96% on a QoQ basis from $5.3 million in Q4 2025.
InMode (INMD) Interest & Investment Income (2018 - 2026) Analysis & Trends
InMode (INMD) has reported Interest & Investment Income for 9 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.
- Quarterly Interest & Investment Income fell 37.37% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.4 million (down 24.93% YoY) and the FY2025 annual result came in at $24.9 million, down 19.38% from the prior year.
- Interest & Investment Income retreated to $4.3 million in Q1 2026 per INMD's latest filing, from $5.3 million in the prior quarter.
- Over the last five years, Interest & Investment Income for INMD reached as high as $9.9 million in Q3 2024 and fell as low as $189000.0 in Q3 2022.
- A 5-year average of $5.4 million and a median of $4.8 million in 2023 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 3257.63% — and 2025, when it sank 52.4%.
- Year by year, Interest & Investment Income stood at $4.0 million in 2022, then jumped by 125.14% to $8.9 million in 2023, then plunged by 51.28% to $4.3 million in 2024, then grew by 21.97% to $5.3 million in 2025, then dropped by 18.96% to $4.3 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $4.3 million, $5.3 million, and $4.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | InMode | 981,130.50 | -479.15 Mn | 61.55 Mn | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 5.30 Mn |
| Sep 30, 2025 | 4.72 Mn |
| Jun 30, 2025 | 8.06 Mn |
| Mar 31, 2025 | 6.86 Mn |
| Dec 31, 2024 | 4.35 Mn |
| Sep 30, 2024 | 9.92 Mn |
| Jun 30, 2024 | 8.69 Mn |
| Mar 31, 2024 | 7.98 Mn |
| Dec 31, 2023 | 8.92 Mn |
| Sep 30, 2023 | 4.95 Mn |
| Jun 30, 2023 | 4.45 Mn |
| Mar 31, 2023 | 3.29 Mn |
| Dec 31, 2022 | 3.96 Mn |
| Sep 30, 2022 | 189,000.00 |
| Mar 31, 2022 | 379,000.00 |
| Dec 31, 2021 | 118,000.00 |
| Sep 30, 2021 | -65,000.00 |
| Jun 30, 2021 | 428,000.00 |
| Mar 31, 2021 | 44,000.00 |